Company Search:
Advanced Search
Sponsored Links
Acasti Pharma Inc Company Snapshot
Acasti Pharma Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acasti Pharma Inc with three other miscellaneous service companies in North America: Agenix Limited of the United States (2016 sales of $22,119.95 ), Cell MedX Corp of the United States ($36,557.00 ), and Pacgen Life Science Corporation (65,611.00 Canadian Dollars [US$50,046.76 ] ).

Sales Analysis. Sales fell dramatically in 2016: During the year ended February of 2016, sales at Acasti Pharma Inc were C$37,656.00 (US$28.72 thousand). This is a sharp decrease of 86.1% versus 2015, when the company's sales were C$270,615.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acasti Pharma Inc
  Stock Performance Chart for Acasti Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 2.13
(Figures in Canadian Dollars)
1 Week -4.1%   13 Weeks -18.7%  
4 Weeks 8.7%   52 Weeks -44.1%  
Acasti Pharma Inc Key Data:
  Ticker: APO Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 37,656
(Year Ending Jan 2017).
Employees: 11
  Currency: Canadian Dollars Market Cap: 22,816,641
  Fiscal Yr Ends: February Shares Outstanding: 10,712,038
  Share Type: Closely Held Shares: 5,400,350
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.